Clinical Trial Update: A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 ADME study in healthy Chinese male subjects to characterize absorption, distribution, metabolism, and excretion of the investigational compound IMP4297.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• IMP4297 (IMP4297)

Snippet

Sponsor: Impact Therapeutics, Inc. | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED